Key result
African American prostate cancer patients exhibit distinct genome-wide mutational profiles vs European and African patients.
Why the study?
Despite known ancestry-related differences in prostate cancer mutations, comprehensive genome-wide mutational comparisons remained limited.
Are there ancestry-related differences in genome-wide mutational patterns among prostate cancer patients?
Population
19 patients across three cohorts including Africans (n=5), African Americans (n=11), and European Americans (n=3)
Comparison
Whole-genome mutational comparisons across African, African American, and European American ancestries
Design
Comparative genomic analysis of whole-genome DNA sequencing data
Authors
Loading...
Requires caution applying European-derived genomic data broadly in prostate cancer; extends prior research and supports ancestry-stratified precision oncology.
Are there ancestry-related differences in genome-wide mutational patterns among prostate cancer patients?
Whole-genome analysis reveals significant ancestry-specific mutational differences in prostate cancer among African, African American, and European American patients.
Korvink et al. (2026) studied this question. African American prostate cancer patients exhibit significantly distinct genome-wide mutational profiles, including substitutions (p=0.0149), compared to European and African patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: